Cancer cells have developed various strategies for evading host anti-cancer immunologic attacks, including the up-regulation of PD-L1, which induces T cell anergy and apoptosis by interacting with programmed death-1 (PD-1) receptors [2, 3]. The gene discussed is CD274; the disease is cancer.